"Since opening our facility in 1994, Bristol Regional Medical Center has served the community through superior quality care, technological innovation and compassion. Bristol Regional continues to be recognized among the nation's best hospitals."

During the past decade, Bristol Regional Medical Center conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 20 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 16 clinical trials were completed. i.e. 106.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bristol Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored and "Eastern Cooperative Oncology Group" with 5 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bristol Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Bristol Regional Medical Center" are "Invasive Breast Carcinoma" (4 trials), "Ovarian Seromucinous Carcinoma" (4 trials), "Breast Cancer" (3 trials), "Clear Cell Renal Cell Carcinoma" (3 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Bristol Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Bristol Regional Medical Center" are "Drug" (51 trials), "Other" (39 trials), "Biological" (19 trials), "Procedure" (16 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (18 trials), "Laboratory Biomarker Analysis" (16 trials), "Computed Tomography" (13 trials), "Paclitaxel" (12 trials) and "Biospecimen Collection" (11 trials). Other intervention names were less common.

The vast majority of trials in "Bristol Regional Medical Center" are 49 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bristol Regional Medical Center". undefined are not yet recruiting, 15 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Bristol Regional Medical Center, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bristol Regional Medical Center, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".